FDAnews
www.fdanews.com/articles/100905-baxter-receives-510-k-clearance-for-v-link

Baxter Receives 510(k) Clearance for V-Link

November 9, 2007

Baxter Healthcare Corporation announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its V-Link Luer-activated device (LAD) with VitalShield protective coating. This new device has been shown to kill 99.9 percent of specific common pathogens (infection-causing microorganisms) known to cause catheter-related blood stream infections, including the highly treatment-resistant bacteria called methicillin-resistant Staphylococcus aureus, or MRSA.
Baxter